Cephracap

PRESENTATION:

Cephracap: Each capsule contains Cephradine USP 500 mg.

Cephracap DS PFS: After reconstitution each 5 ml suspension contains Cephradine USP 250 mg.

INDICATION:

Cephracap (Cephradine) is used in the treatment of infections caused by sensitive organisms. Upper respiratory tract infections: Pharyngitis, sinusitis, otitis media, tonsilitis, laryngotracheo-bronchitis; Lower respiratory tract infections: Acute and chronic bronchitis, lobar and bronchopneumonia.Urinary tract infections: Cystitis, urethritis, pyelonephritis; Skin and soft tissue infections: Abscess, cellulitis, furunculosis, impetigo; Gastrointestinal tract infections: Bacillary dysentery, enteritis, peritonitis. Bone and joint infection; Surgical prophylaxis: It is also used in perioperative prophylactic administration (pre-operatively, intra-operatively and post-operatively). In cesarean section, intra-operative (after clamping the umbilical cord) and post-operative use may reduce the incidence of certain postoperative infections.

PACKAGING:

Cephracap Capsule: Box containing 5X4's capsules in Alu-Alu blister pack.

Cephracap DS PFS: Bottle containing dry powder to reconstitute 100 ml suspension with a measuring cup.